Gyre Therapeutics Inc. (GYRE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Gyre Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.09
+8.58% today
Market cap
$728M
Overall quality
—
Kronos AI 30-day
−2.9%
2 of 8 simulated paths end higher
Gyre Therapeutics Inc. (GYRE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $728M. It trades at $7.09, up 8.58% today. 2 analysts' average target of $19.00 implies +168.0% from today's price. Kronos AI's 30-day forecast is −2.9% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.00 |
| Low – high | $18.00 – $20.00 |
| Analysts | 2 |
| Upside to average | +168.0% |
Kronos AI 30-day forecast
| Expected close | $6.34 (−2.9%) |
| Likely range | −8.3% … +5.2% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.